在癌症和癌症干细胞治疗中,树突细胞衍生的外体的最新进展
Radhwan Abdul Kareem1, Hayder Naji Sameer2, Zainab H Athab3
1Doctor of Dental Surgery, Ahl Al Bayt University, Kerbala, Iraq.
International reviews of immunology
|January 14, 2026
概括
树突细胞衍生外体细胞 (DC-EXOs) 通过向癌症干细胞和激活免疫反应,对癌症治疗有希望. 本研究回顾了它们的治疗潜力,临床应用的优点和缺点.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
背景情况:
- 外体 (EXOs) 是细胞衍生的囊泡,对细胞间通信至关重要,并与癌症进展和免疫调节有关.
- 状细胞 (DCs) 是免疫反应的关键协调者,并用于癌症免疫疗法.
- 树突细胞衍生外体 (DC-EXOs) 是DCs释放的纳米纤维,具有与其母细胞相似的免疫刺激特性.
研究的目的:
- 研究DC-EXO针对癌症干细胞 (CSC) 和各种癌症的治疗潜力.
- 审查基于DC-EXO的癌症治疗的优缺点.
- 探索增强抗癌疗效和针对临床使用DC-EXO的策略.
主要方法:
- 关于DC-EXO在癌症治疗中的作用的文献综述.
- 对DC-EXO的组成和免疫参与分子 (例如,MHC-复合体,共刺激分子) 的分析.
- 检查临床研究数据,包括瘤类载荷DC-EXO的I期试验.
主要成果:
- DC-EXO在向CSC和治疗各种癌症方面显示出巨大的潜力.
- 与基于细胞的DC免疫疗法相比,DC-EXO提供了优势,包括增强免疫细胞介导的瘤根除.
- 瘤酸载入的DC-EXO在I期临床试验中显示出有效性,目前正在进行II期试验.
结论:
- 在癌症治疗中,DC-EXO是一种有前途的无细胞免疫疗法.
- 需要进一步的研究和优化,以最大限度地提高DC-EXO临床应用的抗癌疗效和准能力.
- DC-EXO具有增强针对CSC和各种癌症类型的免疫治疗策略的潜力.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K


